Related references
Note: Only part of the references are listed.Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007-2015): In vivo response and dhfr and dhps mutations
Qutbuddin Kakar et al.
ACTA TROPICA (2016)
In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin
Muturi J. Njokah et al.
MALARIA JOURNAL (2016)
The production and exportation of artemisinin-derived drugs in China: current status and existing challenges
Yangmu Huang et al.
MALARIA JOURNAL (2016)
Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration
Lacramioara Ochiuz et al.
MOLECULES (2016)
Clinical and non-clinical safety of artemisinin derivatives in pregnancy
Caroline Gomes et al.
REPRODUCTIVE TOXICOLOGY (2016)
Halofuginone and artemisinin synergistically arrest cancer cells at the G1/G0 phase by upregulating p21Cip1 and p27Kip1
Guoqing Chen et al.
ONCOTARGET (2016)
Aspirin and NSAIDs for breast cancer chemoprevention
Eugenia Ch Yiannakopoulou
EUROPEAN JOURNAL OF CANCER PREVENTION (2015)
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
Edna Ooko et al.
PHYTOMEDICINE (2015)
A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer
Sanjeev Krishna et al.
EBIOMEDICINE (2015)
Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles
Hanh Thuy Nguyen et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma
Pieter Sonneveld et al.
BLOOD (2015)
Direct Binding of Arsenic Trioxide to AMPK and Generation of Inhibitory Effects on Acute Myeloid Leukemia Precursors
Elspeth M. Beauchamp et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance
David J. Mc Carthy et al.
PHARMACEUTICAL RESEARCH (2015)
A Multifunctional Polymeric Nanotheranostic System Delivers Doxorubicin and Imaging Agents across the Blood-Brain Barrier Targeting Brain Metastases of Breast Cancer
Jason Li et al.
ACS NANO (2014)
Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells
Kai Chen et al.
ANTI-CANCER DRUGS (2014)
Multifunctional mesoporous nanoparticles as pH-responsive Fe2+ reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth
Jian Chen et al.
BIOMATERIALS (2014)
Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis
Fengyun Dong et al.
CANCER BIOLOGY & THERAPY (2014)
Unbiased Compound Screening Identifies Unexpected Drug Sensitivities and Novel Treatment Options for Gastrointestinal Stromal Tumors
Sergei Boichuk et al.
CANCER RESEARCH (2014)
Aspirin in gastrointestinal oncology: new data on an old friend
Ruth E. Langley et al.
CURRENT OPINION IN ONCOLOGY (2014)
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer
Therese Ericsson et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery
S. Jose et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin
Yan Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Artesunate Induces Cell Death in Human Cancer Cells via Enhancing Lysosomal Function and Lysosomal Degradation of Ferritin
Nai-Di Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The activation of c-Jun NH2-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells
Guang Jia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Chronic Thalidomide and Chemoembolization for Hepatocellular Carcinoma
Jennifer wu et al.
ONCOLOGIST (2014)
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
Xiaona Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway
Ling Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and Function
Jia Shen et al.
CELL REPORTS (2014)
Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin
Amir Gharib et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2014)
Metformin in cancer prevention and therapy
Jacek Kasznicki et al.
ANNALS OF TRANSLATIONAL MEDICINE (2014)
Dihydroartemisinin promotes angiogenesis during the early embryonic development of zebrafish
Qian Ba et al.
ACTA PHARMACOLOGICA SINICA (2013)
Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis
Alba G. Blazquez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice
Meihua Jin et al.
DRUG DELIVERY (2013)
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate
Toril Holien et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Synergistic Inhibition of Angiogenesis by Artesunate and Captopril In Vitro and In Vivo
Benjamin Krusche et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Preparation and optimization of transferrin-modified-artemether lipid nanospheres based on the orthogonal design of emulsion formulation and physically electrostatic adsorption
S. E. Eltayeb et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Development of artemisinin compounds for cancer treatment
Henry C. Lai et al.
INVESTIGATIONAL NEW DRUGS (2013)
In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100)
Diego Di Felipe Avila Alcantara et al.
JOURNAL OF APPLIED TOXICOLOGY (2013)
Artemisinin rewires the protein interaction network in cancer cells: network analysis, pathway identification, and target prediction
Chao Huang et al.
MOLECULAR BIOSYSTEMS (2013)
Artemether Combined with shRNA Interference of Vascular Cell Adhesion Molecule-1 Significantly Inhibited the Malignant Biological Behavior of Human Glioma Cells
Ying-Bin Wang et al.
PLOS ONE (2013)
The Artemisinin Derivative Artesunate Inhibits Corneal Neovascularization by Inducing ROS-Dependent Apoptosis in Vascular Endothelial Cells
Rui Cheng et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Artesunate induces G0/G1 cell cycle arrest and iron-mediated mitochondrial apoptosis in A431 human epidermoid carcinoma cells
Zhongyong Jiang et al.
ANTI-CANCER DRUGS (2012)
Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells
Chenjuan Zhou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
LyP-1 Modification To Enhance Delivery of Artemisinin or Fluorescent Probe Loaded Polymeric Micelles to Highly Metastatic Tumor and Its Lymphatics
Zhaohui Wang et al.
MOLECULAR PHARMACEUTICS (2012)
Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1
Qian Ba et al.
PLOS ONE (2012)
Correction: Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
Rui Kong et al.
PLoS One (2012)
An injectable hybrid nanoparticle-in-oil-in-water submicron emulsion for improved delivery of poorly soluble drugs
Shuo Wang et al.
NANOSCALE RESEARCH LETTERS (2012)
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents
Andrew M. Gravett et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway
Shuang-Jia Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase
Yanyan Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
The Role of Heme and the Mitochondrion in the Chemical and Molecular Mechanisms of Mammalian Cell Death Induced by the Artemisinin Antimalarials
Amy E. Mercer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production
Anne Hamacher-Brady et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Anti-tumor effects of dihydroartemisinin on human osteosarcoma
Ye Ji et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Artesunate Induces Oxidative DNA Damage, Sustained DNA Double-Strand Breaks, and the ATM/ATR Damage Response in Cancer Cells
Nicole Berdelle et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The Effects of Artesunate on the Expression of EGFR and ABCG2 in A549 Human Lung Cancer Cells and a Xenograft Model
Hu Ma et al.
MOLECULES (2011)
The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
Youyou Tu
NATURE MEDICINE (2011)
Artesunate mitigates proliferation of tumor cells by alkylating heme-harboring nitric oxide synthase
Qing-Ping Zeng et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2011)
Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells
Jin-Jian Lu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
Shuang-Jia Wang et al.
CANCER LETTERS (2010)
Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
Hao Chen et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB
Hua Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Severe Embryotoxicity of Artemisinin Derivatives in Experimental Animals, but Possibly Safe in Pregnant Women
Qigui Li et al.
MOLECULES (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis
Ikuhiko Nakase et al.
CANCER LETTERS (2009)
The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunate's Activity in Cancer Cells
V. Badireenath Konkimalla et al.
CURRENT CANCER DRUG TARGETS (2009)
Novel Classes of Dimer Antitumour Drug Candidates
Larry M. C. Chow et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFκB p65
Shihui Li et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
Jamin A. Willoughby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
Tao Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species
Jin-Jian Lu et al.
CANCER BIOLOGY & THERAPY (2008)
Artesunate derived from traditional Chinese medicine induces DNA damage and repair
Paul C. H. Li et al.
CANCER RESEARCH (2008)
Experimental therapy of hepatoma with artemisinin and its derivatives:: In vitro and in vivo activity, chemosensitization, and mechanisms of action
Junmei Hou et al.
CLINICAL CANCER RESEARCH (2008)
The antiviral activities of artemisinin and artesunate
Thomas Efferth et al.
CLINICAL INFECTIOUS DISEASES (2008)
Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin
Lin-Na Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells
Deguang Mu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Dihydroartemisinin is an inhibitor of ovarian cancer cell growth
Yang Jiao et al.
ACTA PHARMACOLOGICA SINICA (2007)
Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells
D. Mu et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2007)
Case report of a pituitary macroadenoma treated with artemether
Narendra P. Singh et al.
INTEGRATIVE CANCER THERAPIES (2006)
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells
T Efferth
CURRENT DRUG TARGETS (2006)
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an in vitro replicative system
MR Romero et al.
ANTIVIRAL RESEARCH (2005)
Molecular modes of action of artesunate in tumor cell lines
T Efferth et al.
MOLECULAR PHARMACOLOGY (2003)
Neurotoxic mode of action of artemisinin
G Schmuck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
